A phase I study of AIT-082 in healthy elderly volunteers.
Latest Information Update: 09 Dec 2015
Price :
$35 *
At a glance
- Drugs Leteprinim potassium (Primary)
- Indications Alzheimer's disease; Memory disorders
- Focus Pharmacokinetics
- 05 Nov 2010 New trial record.